GW Pharmaceuticals, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today provided an update on the Company’s cannabinoid pipeline.
Further reading More international news
Leave a Reply
You must be logged in to post a comment.